BOLD
Price:
$1.1
Market Cap:
$24.62M
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc...[Read more]
Industry
Biotechnology
IPO Date
2016-07-20
Stock Exchange
NASDAQ
Ticker
BOLD
According to Boundless Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.41. This represents a change of -41.69% compared to the average of -0.70 of the last 4 quarters.
The mean historical PE Ratio of Boundless Bio, Inc. over the last ten years is -0.11. The current -0.41 PE Ratio has changed 37.99% with respect to the historical average. Over the past ten years (40 quarters), BOLD's PE Ratio was at its highest in in the September 2019 quarter at -0.00. The PE Ratio was at its lowest in in the March 2024 quarter at -4.88.
Average
-0.11
Median
-0.00
Minimum
-0.75
Maximum
-0.00
Discovering the peaks and valleys of Boundless Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 16.75%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -45.08%
Minimum Annual PE Ratio = -0.75
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.75 | 16.75% |
| 2023 | -0.00 | -7.15% |
| 2022 | -0.00 | -45.08% |
| 2021 | -0.00 | 158.11% |
| 2018 | -0.00 | -29.95% |
| 2017 | -0.00 | -33.88% |
The current PE Ratio of Boundless Bio, Inc. (BOLD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.25
5-year avg
-0.15
10-year avg
-0.11
Boundless Bio, Inc.’s PE Ratio is greater than Q32 Bio Inc. (-1.05), greater than NextCure, Inc. (-0.50), greater than Plus Therapeutics, Inc. (-3.42), greater than Intensity Therapeutics, Inc. (-1.69), greater than Iterum Therapeutics plc (-0.75), greater than AN2 Therapeutics, Inc. (-0.86), greater than Pluri Inc. (-0.87), greater than Rallybio Corporation (-0.72), less than Sonnet BioTherapeutics Holdings, Inc. (-0.37), less than TAO Synergies Inc. (-0.37),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.05 | $44.54M | |
| -0.50 | $34.11M | |
| -3.42 | $39.62M | |
| -1.69 | $21.70M | |
| -0.75 | $21.14M | |
| -0.86 | $29.18M | |
| -0.87 | $23.49M | |
| -0.72 | $28.16M | |
| -0.37 | $8.43M | |
| -0.37 | $23.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boundless Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Boundless Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Boundless Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Boundless Bio, Inc. (BOLD)?
What is the highest PE Ratio for Boundless Bio, Inc. (BOLD)?
What is the 3-year average PE Ratio for Boundless Bio, Inc. (BOLD)?
What is the 5-year average PE Ratio for Boundless Bio, Inc. (BOLD)?
How does the current PE Ratio for Boundless Bio, Inc. (BOLD) compare to its historical average?